Clinical trial
Validation of RDQ Questionnaire
NCT00291746 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00291746 |
|---|---|
| Title | Validation of RDQ Questionnaire |
| Official title | A Single-Blind Single Arm Study to Validate the Reflux Disease Questionnaire (RDQ) for the Diagnosis of Reflux Disease in Primary Care in Patients Treated With Esomeprazole 40 mg o.d. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux |
| Intervention type | Drug, Procedure |
| Interventions | Esomeprazole, Bravo technique |
| Enrollment | 350 |
| Start date | Sep 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Feb 15, 2006 |
| Last update posted | Mar 12, 2009 |
| Countries | Canada, Denmark, Germany, Norway, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: